Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OncoSec Medical Inc ONCSQ

Healthcare Biotechnology
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its core technology, ImmunoPulse, is a drug-device therapeutic modality platform comprised of an OncoSec... see more

Recent & Breaking News (GREY:ONCSQ)

OncoSec Medical and the University of Washington Enter Sponsored Research Agreement

Business Wire November 20, 2014

OncoSec Medical and Plexxikon Collaborate to Explore Combination Immunotherapy in Preclinical Tumor Studies

Business Wire November 18, 2014

Medical Device Makers Are Cheering After Latest Victory from GOP

Accesswire November 14, 2014

OncoSec Medical To Present at 2014 Stifel Healthcare Conference

Business Wire November 13, 2014

OncoSec Medical Receives VBHRC Funding to Study Novel Gene Therapy Approach in Melanoma

Business Wire November 10, 2014

OncoSec Medical to Present New Clinical Data at Melanoma Bridge 2014

Business Wire November 5, 2014

OncoSec Medical To Present at Three Events in November

Business Wire November 3, 2014

OncoSec Medical Receives Phase I SBIR Funding for Development of Novel Electroporation Technologies

Business Wire October 27, 2014

OncoSec Medical Announces YTD Results for Fiscal Year End 2014

Business Wire October 10, 2014

OncoSec Medical Announces October Events Agenda

Business Wire September 30, 2014

OncoSec Medical Expands Legal Team, Appoints Sheela Mohan-Peterson as General Counsel and Corporate Secretary

Business Wire September 17, 2014

OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer

Business Wire September 16, 2014

OncoSec Medical to Present Data at ESMO 2014 Congress

Business Wire September 9, 2014

OncoSec Medical to Present at Five Events in September

Business Wire September 2, 2014

OncoSec Medical Appoints Dr. Holbrook Kohrt to Scientific Advisory Board

Business Wire August 6, 2014

OncoSec Medical To Present at 2014 DNA Vaccine Conference

Business Wire July 17, 2014

OncoSec Medical To Present at Bioelectrochemistry Gordon Research Conference on July 8 and July 10

Business Wire July 2, 2014

OncoSec Medical Appoints Dr. Soldano Ferrone to Scientific Advisory Board

Business Wire June 25, 2014

Affymax Inc., OncoSec Medical Inc. See Share Price Decrease In Rough Day For Biotech Sector

Accesswire June 16, 2014

OncoSec Medical Announces YTD Results as of April 30, 2014

Business Wire June 13, 2014